{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": ["IM"], "OtherAbstract": [], "KeywordList": [], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "31580307", "DateCompleted": {"Year": "2020", "Month": "08", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "10", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "09", "Day": "06"}], "Language": ["eng"], "ELocationID": ["10.23750/abm.v90i3.7265"], "Journal": {"ISSN": "2531-6745", "JournalIssue": {"Volume": "90", "Issue": "3", "PubDate": {"Year": "2019", "Month": "Sep", "Day": "06"}}, "Title": "Acta bio-medica : Atenei Parmensis", "ISOAbbreviation": "Acta Biomed"}, "ArticleTitle": "Mechanisms of pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy: a systematic review.", "Pagination": {"StartPage": "213", "EndPage": "217", "MedlinePgn": "213-217"}, "Abstract": {"AbstractText": ["Multiple sclerosis (MS) defines as an intricate disease with numerous pathophysiological processes, including: inflammation, demyelination, oxidative stress, axonal damage, and repair mechanisms that interfere in this disease and highly related to the pathogenesis of MS. In parallel, recent studies have shown that the ozone administration could be very useful in treating neurological disorders and inflammatory and degenerative neurological diseases. In this review, we examine the recent literature on the pathophysiology of blood vessels in patients with multiple sclerosis treated with ozone therapy."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, Baqiyatallah University of Medical Sciences, Tehran, Iran. Mortezaizadimd@yahoo.com."}], "Identifier": [], "LastName": "Ameli", "ForeName": "Javad", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Banki", "ForeName": "Abdolali", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khorvash", "ForeName": "Fariborz", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Simonetti", "ForeName": "Vincenzo", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jafari", "ForeName": "Nematollah Jonaidi", "Initials": "NJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Izadi", "ForeName": "Morteza", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "Italy", "MedlineTA": "Acta Biomed", "NlmUniqueID": "101295064", "ISSNLinking": "0392-4203"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["physiopathology"], "DescriptorName": "Blood Vessels"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Multiple Sclerosis"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}], "CoiStatement": "Each author declares that he or she has no commercial associations (e.g. consultancies, stock ownership, equity interest, patent/licensing arrangement etc.) that might pose a conflict of interest in connection with the submitted article"}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Di Paolo N, Bocci V, Gaggioti E. Ozone therapy editorial review. Int J Artificial Organs. 2004;27:168\u201375.", "ArticleIdList": ["15112882"]}, {"Citation": "Bocci V. Biological and clinical effects of ozone: Has ozone therapy a future in medicine. Br J Biomed Sci. 1999;56:270\u20139.", "ArticleIdList": ["10795372"]}, {"Citation": "Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for the therapy of human immunodeficiency virus infection and several other diseases. Med Hypothesis. 1996;46:150\u20134.", "ArticleIdList": ["8692040"]}, {"Citation": "Braidy N, Izadi M, Sureda A, Jonaidi-Jafari N, Banki A, Nabavi SF, Nabavi SM. Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain. J Cell Physiol. 2017 Jun 8 doi: 10.1002/jcp.26044. [Epub ahead of print]", "ArticleIdList": ["28594115"]}, {"Citation": "Re L, Rowen R, Travagli V. Ozone Therapy and Its Use in Medicine. Cardiology. 2016;134(2):99\u2013100.", "ArticleIdList": ["26919490"]}, {"Citation": "Elwell CE, Cope M, Edwards AD, et al. Quantifcation of adult cerebral hemodynamics by near-infrared spectroscopy. J Appl Physiol. 1994;77:2753\u20132760.", "ArticleIdList": ["7896617"]}, {"Citation": "Lintas G, Molinari F, Simonetti V, et al. Time and timefrequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc. 2013:6171\u20136.", "ArticleIdList": ["24111149"]}, {"Citation": "Molinari F, Acharya UR, Martis RJ, et al. Entropy analysis of muscular near-infrared spectroscopy (NIRS) signals during exercise programme of type 2 diabetic patients: quantitative assessment of muscle metabolic pattern. Comput Methods Programs Biomed. 2013;112:518\u2013528.", "ArticleIdList": ["24075080"]}, {"Citation": "Molinari F, Simonetti V, Franzini M, et al. Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients. Int J Immunopathol Pharmacol. 2014;27:379\u2013389.", "ArticleIdList": ["25280029"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Delgado-Roche L, D\u00edaz-Batista A, P\u00e9rez-Davison G, Re L. Effects of ozone therapy on haemostatic and oxidative stress index in coronary artery disease. Eur. J. Pharmacol. 2012;691:156\u2013162.", "ArticleIdList": ["22796450"]}, {"Citation": "Viebahn R. Heidelberg: Karl F. Haug Publisher; 1994. The Use of Ozone in Medicine."}, {"Citation": "Iliakis E, Valadakis V, Vynios DH, Tisiganos CP, Agapitos E. Rationalization of the activity of medical ozone on intervertebral disc: a histological and biochemical study. Riv Neuroradiol. 2001;14(suppl 1):23\u201330."}, {"Citation": "Bocci V. Doordrecht: Kluwer Academic Publishers; 2002. Oxygen-Ozone Therapy, a Critical Evaluation."}, {"Citation": "Zaky S, et al. Preliminary results of ozone therapy as apossible treatment for patients with chronic hepatitis C. J Altern Complement Med. 2011;17:259\u201363.", "ArticleIdList": ["21417811"]}, {"Citation": "Bocci V, Zanardi I, Travagli V. Ozone: a new therapeutic agent in vascular diseases. Am J Cardiovasc Drugs. 2011:73\u201382.", "ArticleIdList": ["21446774"]}, {"Citation": "Clavo B, et al. Ozone Therapy for Tumor Oxygenation: a Pilot Study. Evidence-based Complement. Altern Med. 2004;1:93\u201398.", "ArticleIdList": ["PMC442111", "15257330"]}, {"Citation": "Shah P, Shyam AK, Shah S. Adjuvant combined ozone therapy for extensive wound over tibia. Indian J Orthop. 2011;45:376\u2013379.", "ArticleIdList": ["PMC3134027", "21772635"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress. Medical Gas Research. 2011;1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Di Filippo C, et al. Acute oxygen-ozone administration torats protects the heart from ischemia reperfusion infarct. Inflamm Res. 2008;57:445\u2013449.", "ArticleIdList": ["18827966"]}, {"Citation": "Chen H, et al. Ozone oxidative preconditioning inhibits inflammation and apoptosis in a rat model of renal ischemia/reperfusion injury. Eur J Pharmacol. 2008;581:306\u201314.", "ArticleIdList": ["18093583"]}, {"Citation": "Bocci V. Autohaemotherapy after treatment of blood with ozone: a reappraisal. J Int Res. 1994;22:131\u2013144.", "ArticleIdList": ["8088420"]}, {"Citation": "Coppola L, Verazzo G, Giuta R, et al. Oxygen-ozone therapy and hemorrheological parameters in peripheral chronic arterial occlusive disease. Trombosi e Aterosclerosi. 1992;3:85\u201389."}, {"Citation": "Rokitansky O, Rokitansky A, Steiner J, et al. Ozontherapie bei peripheren, arteriellen. Durchblutungsstorungen: klinik, biochemishe und blutgasanalytische untersuchungen. In: Wasser IOA, editor. Berlin: Ozon-Weltkongress; 1981. pp. 53\u201375."}, {"Citation": "Wenzel DG, Morgan DL. Interactions of ozone and antineoplastic drugs on rat lung fibroblasts and Walker rat carcinoma cells. Res Commun Chem Pathol Pharmacol. 1983;40:279\u2013287.", "ArticleIdList": ["6878868"]}, {"Citation": "Bocci V, Luzzi E, Corradeschi F, et al. Studies on the biological effects of ozone: III, an attempt to define conditions for optimal induction of cytokines. Lymphokine Cytokine Res. 1993;12:121\u2013126.", "ArticleIdList": ["8324077"]}, {"Citation": "Borrelli E, Diadori A, Zalaffi A, Bocci V. Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int J Ophthalmol. 2012;5(6):708\u201313.", "ArticleIdList": ["PMC3530813", "23275905"]}, {"Citation": "Tylicki L, Niewglowski T, Biedunkiewicz B, Burakowski S, Rutkowski 8. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study. Int J Artif Organs. 2001;24(2):79\u201382.", "ArticleIdList": ["11256512"]}, {"Citation": "Pecorelli A, Bocci V, Acquaviva A, et al. NRF2 activation is involved in ozonated human serum upregulation of HO- I in endothelial cells. Toxicol Appl Pharmacol. 2013;267(1):30\u201340.", "ArticleIdList": ["23253326"]}, {"Citation": "Bocci V. Ozone as a bioregulator. Pharmacology and toxicology of ozone therapy today. J Biol Regul Homeost Agents. 1196b;10:31\u201353.", "ArticleIdList": ["9250885"]}, {"Citation": "Bocci V. Springer: Dordrecht; 2005. Ozone: A new medical drug."}, {"Citation": "Bocci V. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425\u2013435.", "ArticleIdList": ["16624639"]}, {"Citation": "Di Paolo N, Bocci V, Gaggiotti E. Ozone therapy. Int J Artif Organs. 2004;27:168e175.", "ArticleIdList": ["15112882"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of action involved in ozone therapy: is healing induced via a mild oxidative stress. Med Gas Res. 2011;1:29\u201345. 10.1186/2045-9912-1-29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014;13:518\u2013524.", "ArticleIdList": ["24424194"]}, {"Citation": "Viebahn-H\u00e4nsler R, Le\u00f3n OS, Fahmy Z. Ozone in medicine: the low-dose ozone concept-guidelines and treatment strategies. Ozone Sci Eng. 2012;34:408\u2013424."}, {"Citation": "Molinari F, Rimini D, Liboni W, et al. Cerebrovascular pattern improved by ozone autohemotherapy: an entropy-based study on multiple sclerosis patients. Med Biol Eng Comput. 2017;55(8):1163\u20131175.", "ArticleIdList": ["27734309"]}, {"Citation": "Rimini D, Molinari F, Liboni W, Simonetti V, Franzini M. The speed of reinfusion affects the vascular system during ozone major autohemotherapy. Ozone Therapy. 2017;1(3):56\u201360."}, {"Citation": "Molinari F, Simonetti V, Franzini M, et al. Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients. Int J Immunopathol Pharmacol. 2014;27(3):379\u201389.", "ArticleIdList": ["25280029"]}, {"Citation": "Han X, Molinari F, Rossati S. Assessment of Ozone Autohemotherapy on Patients with Multiple Sclerosis by Time-frequency Analysis of Near-infrared Spectroscopy Signals. International Journal of Bioelectromagnetism. 2016;18(1):32\u201337."}, {"Citation": "Bocci V, Brito GS. Ozone therapy in critical patients. Rationale ofthe therapy and proposed guidelines. Riv Ital Ossigeno Ozonoterapia. 2006;5:7\u201311."}, {"Citation": "Viebahn-H\u00e4nsler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in medicine: the low-dose ozone concept-guidelines and treatment strategies. Ozone Sci Eng. 2012;34:408\u201324."}, {"Citation": "Larini A, Bianchi L, Bocci V. The ozone tolerance: I) enhancement of antioxidant enzymes is ozone dose-dependent in jurkat cells. Free Radical Research. 2003;37(11):1163\u20131168.", "ArticleIdList": ["14703728"]}, {"Citation": "Bocci V, Zanardi I, Travagli V. Ozone: a new therapeutic agent in vascular diseases. American Journal of Cardiovascular drugs. 2011;11(2):73\u201382.", "ArticleIdList": ["21446774"]}, {"Citation": "Lintas G, Molinari F, Simonetti V, Franzini M, Liboni W. Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effect in multiple sclerosis, Conference Proceedings of the IEEE Engineering in Medicine & Biology Society. 2013:6171\u20136174.", "ArticleIdList": ["24111149"]}, {"Citation": "Yu L, Lu XJ, Shi HC, Wang Q. Does ozone autohemotherapy have positive effect on neurologic recovery in spontaneous spinal epidural hematoma. American Journal of Emergence Medicine. 2014;32(8):949.e1\u2013949.e2.", "ArticleIdList": ["24602896"]}, {"Citation": "De Monte A, van der Zee H, Bocci V. Major ozonated autohaemotherapy in chronic limb ischemia with ulcerations. Journal of Alternative and Complementary Medicine. 2005;11(2):363\u2013367.", "ArticleIdList": ["15865505"]}, {"Citation": "Di Paolo N, Bocci V, Salvo DP, et al. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. The international journal of Artificial organs. 2005;28(10):1039\u20131050.", "ArticleIdList": ["16288443"]}, {"Citation": "Sospedra M, Martin R. Immunology of multiple sclerosis. Annual Reviews in Immunolology. 2005;23:683\u2013747.", "ArticleIdList": ["15771584"]}, {"Citation": "Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmunity Reviews. 2010;9:A387\u201394.", "ArticleIdList": ["19932200"]}, {"Citation": "Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Annals of Neurolology. 2007;61:504\u201313.", "ArticleIdList": ["17492755"]}, {"Citation": "Simon KC, Munger KL, Ascherio A. XVI European Charcot Foundation lecture: Nutrition and environment, can MS be prevented. Journal of the Neurological Sciences. 2011;311:1\u20138.", "ArticleIdList": ["PMC3351205", "21975017"]}, {"Citation": "Van der Mei IA, Simpson S, Jr., Stankovich J, Taylor BV. Individual and joint action of environmental factors and risk of MS. Neurologic Clinics. 2011;29:233\u201355.", "ArticleIdList": ["21439439"]}, {"Citation": "Kurtzke JF. Geography in multiple sclerosis. Journal of Neurology. 1977;215:1\u201326.", "ArticleIdList": ["67196"]}, {"Citation": "Kurtzke JF. Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region. Acta Neurologica Scandinavica. 1980;62:65\u201380.", "ArticleIdList": ["6971038"]}, {"Citation": "Morovic S, Zamboni P. CCSVI is associated with multiple sclerosis. Neurological Research. 2012;34:770\u2013779.", "ArticleIdList": ["22971467"]}, {"Citation": "Dake MD. Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis: History and Background. Tech Vasc Interv Radiol. 2012;15:94\u2013100.", "ArticleIdList": ["22640498"]}, {"Citation": "Lu F, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci. 2000;177:95\u2013103.", "ArticleIdList": ["10980305"]}, {"Citation": "Gonsette RE. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci. 2008;274:48\u201353.", "ArticleIdList": ["18684473"]}, {"Citation": "Lisak RP. Neurodegeneration in multiple sclerosis: defining the problem. Neurology. 2007;68:S5\u2013S12.", "ArticleIdList": ["17548569"]}, {"Citation": "Greco A, Minghetti L, Sette G, Fieschi C, Levi G. Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology. 1999;53:1876\u20131879.", "ArticleIdList": ["10563647"]}, {"Citation": "Ferretti G, Bacchetti T, Principi F, et al. Increased levels of lipid hydroperoxides in plasma of patientswith multiple sclerosis: a relationship with paraoxonase activity. Mult Scler. 2005;11:677\u2013682.", "ArticleIdList": ["16320727"]}, {"Citation": "Hafler DA. Multiple sclerosis. J Clin Invest. 2004;113:788\u2013794.", "ArticleIdList": ["PMC362131", "15067307"]}, {"Citation": "Araneda S, Commin L, Atlagich M, et al. VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure. Neurotoxicology. 2008;29:920\u2013927.", "ArticleIdList": ["18848842"]}, {"Citation": "Broadwater L, et al. Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochim Biophys Acta - Mol Basis Dis. 2011;1812:630\u2013641.", "ArticleIdList": ["PMC3074931", "21295140"]}, {"Citation": "Delgado-Roche L, Riera-Romo M, Mesta F, et al. Medical ozone promotes Nrf2 phosphorylation reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. Eur J Pharmacol. 2017;811:148\u2013154.", "ArticleIdList": ["28623000"]}, {"Citation": "Lu F, Selak M, O\u2019Connor J, et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci. 2000;177(2):95\u2013103.", "ArticleIdList": ["10980305"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "15"}, {"Year": "2018", "Month": "6", "Day": "14"}, {"Year": "2019", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31580307", "PMC7233748", "10.23750/abm.v90i3.7265"]}}]}